WellSpan Health
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, WellSpan Health sits in the top decile of US sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count).
WellSpan Health: 21 sponsored US clinical trials, 6 recruiting.
WellSpan Health sponsors 21 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 12 completed. 4 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Esophageal Obstruction, with 1 trials.
Top-decile sponsor footprint
WellSpan Health ranks in the top decile of sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
21 total, page 1 of 1
WellSpan-THRIVE Cancer QOL Study
NCT07433660
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department
NCT06603662
Point of Care Ultrasound for the Detection of Esophageal Food Bolus
NCT06507670
Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures
NCT05748366
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
NCT05050617
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
NCT04570553
Effect of Four-Week Wellness Program on Work Engagement Burnout and Sleep in a Healthcare Organization (WEBS)
NCT06779526
Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery
NCT05210556
Quantifying the Benefits of Supervised vs. Unsupervised Pre-habilitation for Patients With Acute ACL Tears
NCT04593264
The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis
NCT04033562
Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome
NCT05257057
The Use of Dye-less Cystoscopy in Assessing Urinary Tract Integrity During Hysterectomy
NCT05190939
Preoperative Antibiotics for Carpal Tunnel Release Surgery
NCT03432858
Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement
NCT03107897
A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial
NCT02409017
Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction
NCT01676350
Point of Care Ultrasound for Suspected Small Bowel Obstruction in the Emergency Department
NCT02190981
Point of Care Ultrasound for Evaluation of Suspected Appendicitis in the Emergency Department
NCT02731924
Collect Breast Cancer Patients' Digital Mammography Images With Corresponding Reports for the Development of Software
NCT00749255
Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis
NCT00762424
Uncomplicated Nausea and Vomiting in the Emergency Department
NCT00778011
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 4 |
Therapeutic Areas
Where WellSpan Health enrollment is open (later-stage tilt)
6 recruiting of 21 indexed (29% open); 12 completed (57%).
Phase mix: 4 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Esophageal Obstruction (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
WellSpan Health: open-pipeline peers nationwide
Peers matched on 21 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
WellSpan Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 21 trials (± recruiting share)
- AEterna Zentaris · 21 trials · 0% recruiting
- Amphastar Pharmaceuticals · 21 trials · 5% recruiting
- Apellis Pharmaceuticals · 21 trials · 10% recruiting
- Array Biopharma, now a wholly owned subsidiary of Pfizer · 21 trials · 0% recruiting
Sponsors near 29% open enrollment (± trial volume)
- 89bio · 29% recruiting · 7 trials
- Alabama Physical Therapy & Acupuncture · 29% recruiting · 14 trials
- AlloSource · 29% recruiting · 7 trials
- Alnylam Pharmaceuticals · 29% recruiting · 49 trials
Related
What to do with this WellSpan Health page
21 registered trials is a research-attention snapshot, not an endorsement of WellSpan Health or any single study.
- 6 of WellSpan Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Esophageal Obstruction is the condition WellSpan Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Esophageal Obstruction trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
WellSpan Health pipeline card: 21 registered trials from official public datasets.Report a data error.